The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

signatope.de

Stage

Seed VC | Alive

Total Raised

$670K

Last Raised

$670K | 5 yrs ago

About Signatope

Signatope develops protein assays that are capable of detecting and quantifying biomarkers for organ damage and drug interactions in blood, urine and tissue. In addition, Signatope offers analytical services for clients in the pharmaceutical and chemical industries.

Signatope Headquarter Location

Markwiesenstr. 55

Reutlingen, D-72770,

Germany

+49 7121 51530802

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Signatope

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Signatope is included in 2 Expert Collections, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

O

Omics

1,265 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Latest Signatope News

Signatope Partners With CPATH to Apply Immuno-MS Approach to Drug Toxicity Testing

Sep 25, 2018

Premium NEW YORK (GenomeWeb) – Protein analytics firm Signatope is applying its amino acid motif-specific antibody technology to identifying and measuring protein biomarkers for drug development. Get the full story with GenomeWeb Premium

  • Where is Signatope's headquarters?

    Signatope's headquarters is located at Markwiesenstr. 55, Reutlingen.

  • What is Signatope's latest funding round?

    Signatope's latest funding round is Seed VC.

  • How much did Signatope raise?

    Signatope raised a total of $670K.

  • Who are the investors of Signatope?

    Investors of Signatope include High-Tech Grunderfonds.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.